Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in CABG Surgery
NCT05778305Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine in coronary artery disease (CAD) (2 arms), sponsored by Ain Shams University. Primary endpoints: Intra-operative ventricular function and Post-operative ventricular function. Started Jan 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05778305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05778305.